{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T10:16:34Z","timestamp":1776161794650,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008696","name":"University of the Punjab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004681","name":"Higher Education Commission Pakistan","doi-asserted-by":"publisher","award":["PHEC\/ARA\/PIRCA\/20409\/18"],"award-info":[{"award-number":["PHEC\/ARA\/PIRCA\/20409\/18"]}],"id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jmgm.2026.109359","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:50:32Z","timestamp":1773942632000},"page":"109359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibitory potential of Morus alba leaf extract and its phytoconstituent against SARS-CoV-2 main protease: An integrative in silico and in vitro analysis"],"prefix":"10.1016","volume":"145","author":[{"given":"Ayesha","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobia","family":"Noreen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-9501","authenticated-orcid":false,"given":"Bushra","family":"Ijaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109359_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5606\/tgkdc.dergisi.2020.09298","article-title":"Coronavirus pandemic and cardiovascular issues","volume":"28","author":"\u015eenay","year":"2020","journal-title":"Turk. J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jmgm.2026.109359_bib2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2026.109359_bib3","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1002\/jmv.27957","article-title":"Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic","volume":"94","author":"Umair","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jmgm.2026.109359_bib4","series-title":"Molecular Medical Microbiology","first-page":"2753","article-title":"COVID-19 epidemiology and prevention","author":"Liu","year":"2024"},{"key":"10.1016\/j.jmgm.2026.109359_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41579-023-01003-z","article-title":"SARS-CoV-2 biology and host interactions","volume":"22","author":"Steiner","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jmgm.2026.109359_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"10.1016\/j.jmgm.2026.109359_bib7","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"ul Qamar","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jmgm.2026.109359_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2026.109359_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.692168","article-title":"Catalytic dyad residues His41 and Cys145 impact the catalytic activity and overall conformational fold of the main SARS-CoV-2 protease 3-chymotrypsin-like protease","volume":"9","author":"Ferreira","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.jmgm.2026.109359_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s42485-023-00105-9","article-title":"Evolutionary aspects of mutation in functional motif and post-translational modifications in SARS-CoV-2 3CLpro (Mpro): an in-silico study","volume":"14","author":"Gupta","year":"2023","journal-title":"J. Protein Proteonomics"},{"key":"10.1016\/j.jmgm.2026.109359_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167324","article-title":"Allosteric regulation of 3CL protease of SARS-CoV-2 and SARS-CoV observed in the crystal structure ensemble","volume":"433","author":"Kidera","year":"2021","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2026.109359_bib12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s11224-022-02089-6","article-title":"Structural differences in 3C-like protease (Mpro) from SARS-CoV and SARS-CoV-2: molecular insights revealed by molecular dynamics simulations","volume":"34","author":"Parmar","year":"2023","journal-title":"Struct. Chem."},{"key":"10.1016\/j.jmgm.2026.109359_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104697","article-title":"SARS-CoV-2 polyprotein substrate regulates the stepwise M(pro) cleavage reaction","volume":"299","author":"Narwal","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2026.109359_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06164-x","article-title":"Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis","volume":"21","author":"Manabe","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jmgm.2026.109359_bib15","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2026.109359_bib16","doi-asserted-by":"crossref","first-page":"40431","DOI":"10.1007\/s11356-020-12200-1","article-title":"Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications","volume":"28","author":"Kumar","year":"2021","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.jmgm.2026.109359_bib17","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.18632\/aging.202867","article-title":"Beneficial effect of Arbidol in the management of COVID-19 infection","volume":"13","author":"Jie","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jmgm.2026.109359_bib18","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.2147\/IDR.S287934","article-title":"Favipiravir use in COVID-19: analysis of suspected adverse drug events reported in the WHO database","volume":"14","author":"Kaur","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.jmgm.2026.109359_bib19","article-title":"Cardiac adverse events with remdesivir in COVID-19 infection","volume":"12","author":"Gupta","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jmgm.2026.109359_bib20","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cmi.2020.05.006","article-title":"Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19","volume":"26","author":"Gevers","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jmgm.2026.109359_bib21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1186\/s12879-020-05698-w","article-title":"Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial","volume":"14","author":"Nojomi","year":"2020","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jmgm.2026.109359_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.815404","article-title":"The immune response to SARS-CoV-2 vaccination: insights learned from adult patients with common variable immune deficiency","volume":"12","author":"Quinti","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmgm.2026.109359_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113977","article-title":"Mutations in SARS-CoV-2: insights on structure, variants, vaccines, and biomedical interventions","volume":"157","author":"Abulsoud","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jmgm.2026.109359_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417473","article-title":"De Novo Potent Peptide Nucleic Acid Antisense Oligomer Inhibitors Targeting SARS-CoV-2 RNA-Dependent RNA Polymerase via Structure-Guided Drug Design","volume":"24","author":"Shehzadi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109359_bib25","first-page":"7","article-title":"Medicinal and aromatic plants: a potential source of novel bioactive compounds showing antiviral efficacy against coronavirus (SARS-CoV-2)","volume":"48","author":"Sharma","year":"2021","journal-title":"Indian J. Ecol."},{"key":"10.1016\/j.jmgm.2026.109359_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.680674","article-title":"Research progress on the antiviral activity of glycyrrhizin and its derivatives in liquorice","volume":"12","author":"Huan","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109359_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1775704","article-title":"Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells","volume":"40","author":"Kumar","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109359_bib28","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.26452\/ijrps.v11iSPL1.4194","article-title":"Tinospora cordifolia-An immunomodulatory drug in Ayurveda for prevention and treatment of COVID-19","volume":"11","author":"Khan","year":"2020","journal-title":"Int. J. Res. Pharm. Sci."},{"key":"10.1016\/j.jmgm.2026.109359_bib29","first-page":"1","article-title":"Morus alba and active compound oxyresveratrol exert anti-inflammatory activity via inhibition of leukocyte migration involving MEK\/ERK signaling","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.jmgm.2026.109359_bib30","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3390\/molecules25081876","article-title":"Advances on antiviral activity of Morus spp. plant extracts: human coronavirus and virus-related respiratory tract infections in the spotlight","volume":"25","author":"Thabti","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2026.109359_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118719","article-title":"Antiviral activity of Morus alba L. extract against pseudorabies virus","volume":"336","author":"Zhang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jmgm.2026.109359_bib32","article-title":"Bioactive phenolic compounds isolated in morus alba leaves as potential inhibitor of Hepatitis C Virus NS3 Protease: a molecular docking approach","volume":"5","author":"Friday","year":"2020","journal-title":"Commun. Phys. Sci."},{"key":"10.1016\/j.jmgm.2026.109359_bib33","article-title":"Virtual screening of potential phyto-candidates as therapeutic leads against SARS-CoV-2 infection","volume":"4","author":"Dharmashekara","year":"2021","journal-title":"Environ. Chall."},{"key":"10.1016\/j.jmgm.2026.109359_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.106894","article-title":"Exploring antiviral activity of Betanin and Glycine Betaine against dengue virus type-2 in transfected Hela cells","volume":"195","author":"Mufti","year":"2024","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jmgm.2026.109359_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1735-5362.394818","article-title":"In-silico study MM\/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease","volume":"19","author":"Abbasi","year":"2024","journal-title":"Research in pharmaceutical sciences"},{"key":"10.1016\/j.jmgm.2026.109359_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpha.2020.04.008","article-title":"Structural elucidation of SARS-CoV-2 vital proteins: computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase","volume":"10","author":"Mirza","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jmgm.2026.109359_bib37","first-page":"1","article-title":"Design and molecular dynamic investigations of 7, 8-dihydroxyflavone derivatives as potential neuroprotective agents against alpha-synuclein","volume":"10","author":"Mohankumar","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109359_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12982-024-00140-x","article-title":"Evolution and implications of SARS-CoV-2 variants in the post-pandemic era","volume":"21","author":"Manirambona","year":"2024","journal-title":"Discov. Public Health"},{"key":"10.1016\/j.jmgm.2026.109359_bib39","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20231395","article-title":"3-chymotrypsin-like protease in SARS-CoV-2","volume":"44","author":"Al Adem","year":"2024","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.jmgm.2026.109359_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.151","article-title":"The SARS-CoV-2 main protease (M(pro)): structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm"},{"key":"10.1016\/j.jmgm.2026.109359_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-88388-4","article-title":"Identification of potential SARS-CoV-2 inhibitors among well-tolerated drugs using drug repurposing and in vitro approaches","volume":"15","author":"Oru\u00e7o\u011flu","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109359_bib42","article-title":"Optimization of a novel expression system for recombinant protein production in CHO cells","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109359_bib43","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/bit.28961","article-title":"An overview of virus\u2010free protein expression in insect cells: a mode of rapid manufacturing platform for therapeutic protein and virus\u2010like\u2010particles","volume":"122","author":"Mahadevan","year":"2025","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jmgm.2026.109359_bib44","article-title":"A simplified cell-based assay to identify coronavirus 3CL protease inhibitors","author":"Resnick","year":"2020","journal-title":"bioRxiv : the preprint server for biology"},{"key":"10.1016\/j.jmgm.2026.109359_bib45","article-title":"The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper","volume":"11","author":"Belenkaya","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jmgm.2026.109359_bib46","article-title":"Antiviral potential of selected medicinal herbs and their isolated natural products","volume":"8","author":"Perera","year":"2021","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jmgm.2026.109359_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13002-021-00449-w","article-title":"The use of medicinal plants to prevent COVID-19 in Nepal","volume":"17","author":"Khadka","year":"2021","journal-title":"J. Ethnobiol. Ethnomed."},{"key":"10.1016\/j.jmgm.2026.109359_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1460604","article-title":"Effect of natural products on host cell autophagy induced by Influenza A virus infection","volume":"14","author":"Liu","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jmgm.2026.109359_bib49","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/ph14101055","article-title":"In vitro effect of Taraxacum officinale leaf aqueous extract on the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614 and four mutants","volume":"14","author":"Tran","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jmgm.2026.109359_bib50","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/acs.jnatprod.0c01324","article-title":"Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives","volume":"84","author":"Sa-ngiamsuntorn","year":"2021","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.jmgm.2026.109359_bib51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4308\/hjb.32.2.356-366","article-title":"In silico and in vitro inhibitory activity of Indonesian herbal compound extracts against SARS-COV-2 recombinant papain-like protease","volume":"32","author":"Fatiningtyas","year":"2024","journal-title":"HAYATI J. Biosci."},{"key":"10.1016\/j.jmgm.2026.109359_bib52","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/foods10071503","article-title":"Potential In vitro inhibition of selected plant extracts against SARS-CoV-2 Chymotripsin-Like protease (3CLPro) activity","volume":"10","author":"Guijarro-Real","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.jmgm.2026.109359_bib53","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/molecules29050998","article-title":"Identification of phytochemicals from arabian peninsula medicinal plants as strong binders to SARS-CoV-2 proteases (3CLPro and PLPro) by molecular docking and dynamic simulation studies","volume":"29","author":"Saquib","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2026.109359_bib54","first-page":"3396","article-title":"Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CL(pro)): an in silico screening of alkaloids and terpenoids from African medicinal plants","volume":"39","author":"Gyebi","year":"2021","journal-title":"J. Biomol. Struct. Dynam."},{"key":"10.1016\/j.jmgm.2026.109359_bib55","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1007\/s12033-024-01253-z","article-title":"In silico analysis of calotropis procera-derived phytochemicals targeting 3CL proteoase of SARS-CoV-2","volume":"67","author":"Shafique","year":"2025","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.jmgm.2026.109359_bib56","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.13005\/bpj\/3014","article-title":"Phytochemistry and potential pharmacological properties of Morus alba plant for health benefits: a comprehensive review","volume":"17","author":"Mishra","year":"2024","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.jmgm.2026.109359_bib57","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3390\/molecules28031213","article-title":"Biosynthesized silver nanoparticles using Morus alba (white mulberry) leaf extract as potential antibacterial and anticancer agents","volume":"28","author":"Kumkoon","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jmgm.2026.109359_bib58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12906-024-04586-z","article-title":"Exploring the therapeutic potential of Thai medicinal plants: in vitro screening and in silico docking of phytoconstituents for novel anti-SARS-CoV-2 agents","volume":"24","author":"Maikhunthod","year":"2024","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.jmgm.2026.109359_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9040756","article-title":"A Study of 3CLpros as promising targets against SARS-CoV and SARS-CoV-2","volume":"9","author":"Jo","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jmgm.2026.109359_bib60","article-title":"Mulberry component kuwanon C exerts potent therapeutic efficacy in vitro against COVID-19 by blocking the SARS-CoV-2 spike S1 RBD: ACE2 receptor interaction","volume":"23","author":"Kim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109359_bib61","first-page":"601","article-title":"Integrating In-Vitro experiments and In-Silico approaches identified antiviral activity of Black mulberry (Morus Nigra) as A potential treatment option for SARS-CoV-2. Egypt","volume":"68","author":"Bouback","year":"2025","journal-title":"J. Chem."},{"key":"10.1016\/j.jmgm.2026.109359_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091339","article-title":"Recent advances in SARS-CoV-2 main protease inhibitors: from Nirmatrelvir to future perspectives","volume":"13","author":"Citarella","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jmgm.2026.109359_bib63","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/BCJ20230027","article-title":"Key allosteric and active site residues of SARS-CoV-2 3CLpro are promising drug targets","volume":"480","author":"Al Adem","year":"2023","journal-title":"Biochem. J."},{"key":"10.1016\/j.jmgm.2026.109359_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.medntd.2023.100257","article-title":"Binding kinetics of ten small-molecule drug candidates on SARS-CoV-2 3CLpro revealed by biomolecular simulations","volume":"20","author":"Zhou","year":"2023","journal-title":"Medicine in Novel Technology and Devices"},{"key":"10.1016\/j.jmgm.2026.109359_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105231","article-title":"A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle","volume":"142","author":"Kumar","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jmgm.2026.109359_bib66","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.2147\/IJGM.S361001","article-title":"A review on the antiviral activity of functional foods against COVID-19 and viral respiratory tract infections","volume":"15","author":"Omer","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.jmgm.2026.109359_bib67","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.2147\/DDDT.S302617","article-title":"Mechanism of action of nicotiflorin from Tricyrtis maculata in the treatment of acute myocardial infarction: from network pharmacology to experimental pharmacology","volume":"15","author":"Yu","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jmgm.2026.109359_bib68","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11030-021-10209-3","article-title":"Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors","volume":"26","author":"Shakya","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2026.109359_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38134-5","article-title":"Investigation of the therapeutic role of native plant compounds against colorectal cancer based on system biology and virtual screening","volume":"13","author":"Alibakhshi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmgm.2026.109359_bib70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1142\/S0192415X21500099","article-title":"Mori ramulus and its major component morusin inhibit herpes simplex virus type 1 replication and the virus-induced reactive oxygen species","volume":"49","author":"Kim","year":"2021","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.jmgm.2026.109359_bib71","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jsps.2022.05.003","article-title":"Virtual screening and molecular dynamics simulation analysis of Forsythoside A as a plant-derived inhibitor of SARS-CoV-2 3CLpro","volume":"30","author":"Bibi","year":"2022","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.jmgm.2026.109359_bib72","series-title":"Computer-Aided Drug Design","first-page":"133","article-title":"Molecular dynamics simulation of protein and protein\u2013ligand complexes","author":"Shukla","year":"2020"},{"key":"10.1016\/j.jmgm.2026.109359_bib73","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1080\/07391102.2021.1902395","article-title":"Berberis lyceum and Fumaria indica: in vitro cytotoxicity, antioxidant activity, and in silico screening of their selected phytochemicals as novel hepatitis C virus nonstructural protein 5A inhibitors","volume":"40","author":"Brice Landry","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109359_bib74","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1038\/s41467-024-49858-x","article-title":"Accurate prediction of protein structural flexibility by deep learning integrating intricate atomic structures and Cryo-EM density information","volume":"15","author":"Song","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jmgm.2026.109359_bib75","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3390\/ph16040555","article-title":"Drug repurposing of FDA compounds against \u03b1-Glucosidase for the treatment of type 2 diabetes: insights from molecular docking and molecular dynamics simulations","volume":"16","author":"Rashid","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jmgm.2026.109359_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/v17111435","article-title":"Dual inhibitory potential of conessine against HIV and SARS-CoV-2: Structure-guided molecular docking analysis of critical viral targets","volume":"17","author":"Abdulkareem","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2026.109359_bib77","article-title":"Identification of potential Akt activators: a ligand and structure-based computational approach","volume":"28","author":"Kumar","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2026.109359_bib78","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/14756366.2018.1543288","article-title":"Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies","volume":"34","author":"Cavdar","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.jmgm.2026.109359_bib79","doi-asserted-by":"crossref","DOI":"10.56499\/jppres23.1719_12.2.264","article-title":"Activity of propolis compounds as potential MMP1 and MMP2 inhibitors by in silico studies in wound healing application","volume":"12","author":"Arda","year":"2024","journal-title":"J. Pharm. Pharmacogn. Res."},{"key":"10.1016\/j.jmgm.2026.109359_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.730288","article-title":"Identification of natural inhibitors against SARS-CoV-2 drugable targets using molecular docking, molecular dynamics simulation, and MM-PBSA approach","volume":"11","author":"Kushwaha","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jmgm.2026.109359_bib81","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11483-025-09957-8","article-title":"Inhibition effects of some phenolic anthraquinone derivatives on lactoperoxidase activity: a detailed in vitro and in Silico investigation","volume":"20","author":"Korkmaz","year":"2025","journal-title":"Food Biophys."},{"key":"10.1016\/j.jmgm.2026.109359_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1189786","article-title":"Target specific inhibition of West Nile virus envelope glycoprotein and methyltransferase using phytocompounds: an in silico strategy leveraging molecular docking and dynamics simulation","volume":"14","author":"Akash","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jmgm.2026.109359_bib83","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1080\/07391102.2023.2196703","article-title":"Revealing anti-fungal potential of plant-derived bioactive therapeutics in targeting secreted aspartyl proteinase (SAP) of Candida albicans: a molecular dynamics approach","volume":"42","author":"Dhanasekaran","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109359_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1306046","article-title":"A computational examination of the therapeutic advantages of fourth-generation ALK inhibitors TPX-0131 and repotrectinib over third-generation lorlatinib for NSCLC with ALK F1174C\/L\/V mutations","volume":"10","author":"Balasundaram","year":"2024","journal-title":"Front. Mol. Biosci."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:17:19Z","timestamp":1776158239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":84,"alternative-id":["S1093326326000859"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109359","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory potential of Morus alba leaf extract and its phytoconstituent against SARS-CoV-2 main protease: An integrative in silico and in vitro analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109359"}}